Active Ingredient: CLOBETASOL PROPIONATE
Proprietary Name: BYQLOVI
Dosage Form; Route of Administration: SUSPENSION/DROPS; OPHTHALMIC
Strength: 0.05%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N218158
Product Number: 001
Approval Date: Mar 4, 2024
Applicant Holder Full Name: HARROW EYE LLC
Marketing Status:
Prescription
Patent and Exclusivity Information